Exelixis
S&P 400
$56.12
-2.28%
Delayed · cached 15 min
Fair value analysis
EXEL
Exelixis
$56.12
Close used for this calculation
$57.25Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
71/100
Quality radar
Consensus fair value
$57.25
Near FV▲ +2.0% against the close used
Model range $44.01 – $83.40
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear$44.01Fair value$57.25Bull$83.40
FairClose
52-week traded range
52W low $34.5452W high $59.13
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading close to the consensus fair value
Exelixis closed at $56.12, 2.0% below the consensus fair value of $57.25 drawn from 7 valuation models.
Financial DNA score 71/100 — Strong. P/E of 20.2x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
$61.76
+10.0%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
P/E Fair Value
$55.60
-0.9%
EPS × 20x (sector P/E)
EPS=2.78, Sector P/E=20x
Peter Lynch (PEG)
$83.40
+48.6%
EPS × Growth% (PEG = 1 is fair)
EPS=2.78, g=30%
EV/EBITDA
$57.63
+2.7%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=901.25M
Book Value (P/B)
$64.72
+15.3%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=7.1, ROE=42.4%, g=6%, r=10%
Reverse DCF
$56.12
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 7.3% | Historical: 33.6%
Margin of Safety
$44.01
-21.6%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=58.68, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.